Table 1:
Microbiota variable |
IBS subtype |
Summary of finding | References |
---|---|---|---|
Alpha diversity | Both | Reduced in cross-sectional samples or samples with high symptom severity | 16, 18, 20, 21 |
Microbiota stability | IBS-C | Larger temporal variability of fecal community than healthy control samples | 18 |
Proteobacteria | Both | Elevated in mucosal community from biopsy samples | 18, 19 |
Streptococci | Both | Elevated in fecal community, positively associated with high symptom severity | 16-18 |
Ruminococci | Both | Elevated in phylogenetic microarray studies, but not reported in sequencing studies | 19, 89 |
Lachnospiraceae | Both | Elevated in fecal community, implicated in reduced fecal hypoxanthine levels | 16, 18, 90, 91 |
Methanobrevibacter smitthii | Both | Functionally implicated in constipation but differentially abundant in very few sequencing studies | 89 |
Alistipes | Both | Bile tolerant bacteria, have been associated to pain | 19 |